secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK:        0000875320
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0000875320-23-000047
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vertex appoints Nancy Thornberry to board of directors
------------------------------------------------------

- Nancy Thornberry, former CEO of Kallyope and ex-Merck executive, joins the board effective December 5, 2023.
- Board size increased from 10 to 11 members with Thornberry's appointment.
- Thornberry received a $400,000 restricted stock unit award vesting in December 2024.
- No related party transactions or arrangements with any other persons were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875320/000087532023000047/0000875320-23-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875320/000087532023000047/vrtx-20231205.htm
  HTML page:      https://secwatch.observer/filing/0000875320-23-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer